MODERATE PLAQUE PSORIASIS
Clinical trials for MODERATE PLAQUE PSORIASIS explained in plain language.
Never miss a new study
Get alerted when new MODERATE PLAQUE PSORIASIS trials appear
Sign up with your email to follow new studies for MODERATE PLAQUE PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Head-to-Head: which psoriasis drug works better?
Disease control CompletedThis study compared two already-approved medications, risankizumab (injections every 12 weeks) and deucravacitinib (daily pills), in 393 adults with moderate plaque psoriasis who had not used biologic treatments before. The goal was to see which drug more effectively clears skin …
Matched conditions: MODERATE PLAQUE PSORIASIS
Phase: PHASE4 • Sponsor: AbbVie • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New hope for psoriasis sufferers: drug clears stubborn patches
Symptom relief CompletedThis study tested a drug called guselkumab against a placebo in 338 adults with moderate plaque psoriasis that also affects special areas like the scalp or genitals. The goal was to see if the drug could clear or nearly clear the skin. Results showed that guselkumab was more effe…
Matched conditions: MODERATE PLAQUE PSORIASIS
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Symptom relief
Last updated May 17, 2026 03:43 UTC